0001953017-22-000001.txt : 20221206
0001953017-22-000001.hdr.sgml : 20221206
20221206110810
ACCESSION NUMBER: 0001953017-22-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20221206
DATE AS OF CHANGE: 20221206
EFFECTIVENESS DATE: 20221206
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Lusaris Therapeutics, Inc.
CENTRAL INDEX KEY: 0001953017
IRS NUMBER: 872970305
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-466642
FILM NUMBER: 221446968
BUSINESS ADDRESS:
STREET 1: 200 BERKELEY STREET, 18TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
BUSINESS PHONE: 617-778-2500
MAIL ADDRESS:
STREET 1: 200 BERKELEY STREET, 18TH FLOOR
CITY: BOSTON
STATE: MA
ZIP: 02116
D
1
primary_doc.xml
X0708
D
LIVE
0001953017
Lusaris Therapeutics, Inc.
630 Davis Drive, Suite 220
Morrisville
NC
NORTH CAROLINA
27560
617-778-2500
DELAWARE
None
None
Corporation
true
2021
Edward
Monaghan
C/O LUSARIS THERAPEUTICS, INC.
630 Davis Drive, Suite 220
Morrisville
NC
NORTH CAROLINA
27560
Executive Officer
Director
Promoter
Andrew
Levin
C/O LUSARIS THERAPEUTICS, INC.
630 Davis Drive, Suite 220
Morrisville
NC
NORTH CAROLINA
27560
Executive Officer
Director
Daniel
Grau
C/O LUSARIS THERAPEUTICS, INC.
630 Davis Drive, Suite 220
Morrisville
NC
NORTH CAROLINA
27560
Director
Catherine
Riesen
C/O LUSARIS THERAPEUTICS, INC.
630 Davis Drive, Suite 220
Morrisville
NC
NORTH CAROLINA
27560
Executive Officer
Neil
Buckley
C/O LUSARIS THERAPEUTICS, INC.
630 Davis Drive, Suite 220
Morrisville
NC
NORTH CAROLINA
27560
Executive Officer
Ramin
Farzaneh-Far
C/O LUSARIS THERAPEUTICS, INC.
630 Davis Drive, Suite 220
Morrisville
NC
NORTH CAROLINA
27560
Executive Officer
Pharmaceuticals
Decline to Disclose
- 06b
false
2022-10-13
false
true
false
0
60156164
60156164
0
false
9
0
0
0
false
Lusaris Therapeutics, Inc.
Andrew Levin
Andrew Levin
Interim Chief Executive Officer
2022-12-06